Source / information
Published by:
Disclosure:
Volberding says he is a consultant for Gilead Sciences and chairs a data security supervisory committee for Merck. Wilson does not report any relevant financial information.
ADD SUBJECT TO EMAIL ALERTS
Receive an email when new articles are published on
Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe
We could not process your request. Please try again later. If this problem persists, please contact [email protected].
Back to Healio
During the pandemic, clinicians and scientific publications adapted a number of methods to rapidly disseminate COVID-19 research – especially online.
In line with social distancing measures, major data sharing conferences such as IDWeek, the Conference on Retroviruses and Opportunistic Infections, and the AAP National Conference & Exhibition were held virtually.
Keeping up with the large volume of published COVID-19 research can be challenging, said the editor-in-chief of Infectious Disease News Paul A. Volberding, MD, Professor Emeritus of Medicine at the University of California, San Francisco.
“There’s a lot of research going on, especially for clinical trials,” Volberding told Healio. “There are now these large platform files that display data on a variety of drugs and at different stages of the disease. It seems like a new process is reported every time you turn around. “
Experts expressed concern about the rapid release of COVID-19 research at the start of the pandemic. Volberding said that “careful peer review” of data is important, and researchers should be careful not to exaggerate their findings in a finished paper.
“We want information to come out quickly, but it doesn’t have to come out right away,” he said. “There are a few exceptions to this, for example if there is an important side effect.”
A recent analysis published in Clinical Infectious Diseases detailed how interactive webinars can be used to disseminate knowledge.
Kathryn Wilson
“The results of this manuscript show how an interactive, large-scale series of webinars reached wide audiences of colleagues around the world to quickly share guidance and information on COVID-19 infection prevention and control.” Kathryn Wilson, MPH, an epidemiologist in the CDC’s Department of Health Promotion, said Healio.
“Virtual knowledge networks, such as the one created here in cooperation with the ECHO project” – the Extension for Community Healthcare Outcomes – “are an important resource for the rapid dissemination of clinical guidelines and implementation experience and can be promoted in order to increase the equity of knowledge among colleagues. Said Wilson.
Wilson and colleagues adapted the ECHO model to create a “global knowledge network” and hosted 13 webinar sessions for infection prevention and control experts. The virtual sessions, which took place between May 14 and August 6, 2020, were attended by participants from an average of more than 100 countries.
Wilson said the pandemic had caused a “rapid shift” in medical information sharing and that translations between spoken and written languages for virtual platforms like ECHO were an “area for improvement” in the future.
“The opportunity to hear examples of guideline implementation from around the world and to interact with subject matter experts for quick answers to infection prevention and control questions was extremely valuable,” said Wilson. “We believe that virtual knowledge networks and communities of practice play an important role after a pandemic and should be further developed and promoted.”
ADD SUBJECT TO EMAIL ALERTS
Receive an email when new articles are published on
Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe
We could not process your request. Please try again later. If this problem persists, please contact [email protected].
Back to Healio
